Patents by Inventor Katri Selander

Katri Selander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090191185
    Abstract: Provided herein are methods and compositions for reducing the invasiveness of cancer cells. Such methods and compositions are particularly useful for cancer cells that express a member of the Toll Like Receptor9 (TLR9) subfamily and are useful in selecting the proper treatment for a subject with cancer.
    Type: Application
    Filed: April 13, 2007
    Publication date: July 30, 2009
    Applicant: THE UAB RESEARCH FOUNDATION
    Inventor: Katri Selander
  • Publication number: 20090075941
    Abstract: Methods of treating a subject with neoplasm (e.g., mesothelioma) or at risk of developing neoplasm by administering a mevalonate pathway inhibitor such as a nitrogen-containing bisphosphonate are disclosed. Examples of nitrogen-containing bisphosphonates include alendronate, ibandronate, minodronate, neridronate, olpadronate, pamidronate, risedronate, and zoledronate. The methods can further include the administration of a p38 inhibitor. Further disclosed are compositions and kits including a nitrogen-containing bisphosphonate and optionally a p38 inhibitor.
    Type: Application
    Filed: April 11, 2007
    Publication date: March 19, 2009
    Applicant: THE UAB RESEARCH FOUNDATION
    Inventors: Katri Selander, Pierre Triozzi
  • Publication number: 20040014726
    Abstract: The present invention is directed to a method for the preparation of a pharmaceutical composition having osteoclast formation inhibiting or suppressing activity, characterized in that, as the active agent, a compound of the formula (I) is used, in which formula Q1 is hydrogen, hydroxyl, halogen, amino —NH2, or —OR′, wherein R′ is C1-C4-alkyl or acyl, Q2 is straight or branched alkyl, hydroxyalkyl or aminoalkyl, or a corresponding unsaturated group optionally substituted at the hydroxy or amino group, or a unsubstituted or substituted, saturated or unsaturated cycloalkyl, which can be bound to the methylene carbon over a straight or branched alkylene group, or is the group (a) wherein Y is a saturated or unsaturated heterocyclic group, or a carbocyclic aromatic group, X is a bond, O, S or NR3, wherein R3 is hydrogen or a protecting group, especially lower alkyl, acyl, aryl or arylalkyl, and n is an integer 0 to 6, R1 and R2 are independently hydrogen or C1-C4-alkyl, or it is halogen, an
    Type: Application
    Filed: April 25, 2003
    Publication date: January 22, 2004
    Inventors: Thua Osterman, Ritva Hannuniemi, Teuvo Hentunen, Sirpa Liukko-Sipi, Hannu Nikander, Katri Selander, Raija Sellman, Kalervo Vaananen